Author:
Imaz Arkaitz,del Saz Sara Villar,Ribas M Angels,Curran Adrian,Caballero Estrella,Falcó Vicenç,Crespo Manel,Ocaña Inma,Diaz Marjorie,de Gopegui Enrique Ruiz,Riera Melcior,Ribera Esteban
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Infectious Diseases
Reference20 articles.
1. Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.;Tozzi;Antiviral Ther,2006
2. Time to virologic failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.;Mocroft;J Infect Dis,2004
3. Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions.;Eron;J Infect Dis,2008
4. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.;Clotet;Lancet,2007
5. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.;Madruga;Lancet,2007
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献